Pfizer’s Eliquis Stops Blood Clots as Well as Standard

Eliquis, the blood thinner sold by Pfizer Inc. and Bristol-Myers Squibb Co., was as good as the current standard of care in preventing blood clots and with fewer bleeding complications, according to a study.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.